Why the 29% Drop in NSLU11 Dividends Is Not a Problem
Intermediate PTENES

Why the 29% Drop in NSLU11 Dividends Is Not a Problem

The new payout of R$ 1.8055 per unit still tops our projected baseline of R$ 1.72, reflecting the natural tapering of extraordinary litigation-related distributions.

Why Did NSLU11 Dividends Fall 29%?

Because extraordinary payments from a legal settlement are winding down, but the announced distribution of R$ 1.8055 per unit still exceeds our projected recurring baseline of R$ 1.72. The announcement of the payout of R$ 1.8055 per unit (referating to the July 2026 competence period, payable on Aug 9, 2026) represents a 29% drop compared to the previous payment of R$ 2.55 per unit. However, this reduction should not be viewed as an operational deterioration of the NSLU11 real estate fund. On the contrary, it reflects the natural tapering of extraordinary distributions that inflated yields in recent months.

For investors checking platforms like nslu11 status invest or nslu11 funds explorer, the monthly dividend fluctuation might look alarming at first glance. But the truth is that the fund's actual recurring yield, established after its landmark October 2025 settlement with Rede D'Or, remains solid and in line with expectations. We had already warned that the high dividend yield of the past 12 months was a temporary distortion driven by large judicial payouts, such as the one-time payment of R$ 10.16 per unit in October 2025, alongside other amounts distributed throughout 2026, such as R$ 3.746 per unit in February 2026, R$ 2.05 per unit in March 2026, and R$ 3.6295 per unit in June 2026. The current level of R$ 1.8055 per unit remains above the recurring baseline of R$ 1.72 per unit, showing that the fund maintains its capacity to generate predictable income.

Latest Payout R$ 1.8055 July/2026 Competence
Recurring Yield R$ 1.72 Analysis Projection
Current Price R$ 173.98 Close of Jan 9, 2026
P/BV 0.6871 Book Value Discount

What Is the NSLU11 FII and What Is Its Investment Thesis?

The NSLU11 FII functions much like a 30-year fixed-income real estate instrument structured as a Brazilian real estate fund (FII). The fund holds a single physical asset: the building and land of the Hospital Nossa Senhora de Lourdes, located in the Jabaquara neighborhood of São Paulo. This property is fully leased to Rede D'Or, Brazil's largest private hospital network. Managed by BTG Pactual (the country's largest FII administrator), the fund's role essentially consists of collecting monthly rent from this operation and passing net proceeds along to unitholders, tax-free for individual investors.

Unlike other equity-oriented real estate funds that pursue active growth, property acquisitions, or tenant diversification, the NSLU11 B3 operates on a closed-end, static model. There is no active portfolio management, no expansion thesis, and no reinvestment of earnings to purchase new hospitals. By buying an NSLU11 unit, investors acquire exclusively the right to cash flows generated by the lease agreement with Rede D'Or through 2055, alongside the residual ownership of the physical property at the end of that three-decade term. The thesis is purely focused on predictable, inflation-indexed long-term income.

How Does the Rede D'Or Settlement Affect Monthly Dividends?

The legal settlement reached in October 2025 concluded a 14-year legal dispute between the fund and Rede D'Or, bringing complete contract predictability for the coming decades. This agreement established a new atypical lease agreement running through 2055, setting a fixed monthly rent of R$ 1.84 million, adjusted annually by the IPCA inflation index. Additionally, the deal established an extra monthly payment of R$ 605,000 through 2040, serving as compensation for residual amounts accumulated during the litigation years.

This contractual framework explains why the NSLU11 pays monthly dividends so regularly, while also clarifying recent fluctuations. The base rental flow (R$ 1.84 million) plus the extra installment (R$ 605,000) underpins the sustainability of the recurring dividend of R$ 1.72 per unit. Any distribution above that level—such as the R$ 2.55 per unit paid previously or the R$ 3.6295 per unit distributed in June 2026—stems from extraordinary events, such as the release of old escrow deposits or one-off cash adjustments. Investors should understand that the newly announced payout of R$ 1.8055 per unit still carries a small extraordinary cushion, and the natural trend is for distributions to stabilize gradually around R$ 1.72 per unit, adjusted for inflation.

Competence Month Dividend per Unit (R$)
July/2026 (Latest) 1.8055
June/2026 2.5500
May/2026 3.6295
April/2026 2.0500
March/2026 3.7460
February/2026 16.6904

What Is the Impact of the Asset Revaluation on the NSLU11 Price?

An asset revaluation conducted in late 2025 reduced the hospital's fair value by 17.45%, triggering a notable accounting adjustment in the fund's book value per unit. The technical appraisal report prepared by consulting firm Binswanger in October 2025 lowered the fair value of the Hospital Nossa Senhora de Lourdes from R$ 260.6 million to R$ 215.1 million, representing a book value loss of R$ 45.5 million. This markdown reflects shifts in the new contract's financial assumptions: the capitalization rate (cap rate) rose from 9.5% to 10.5%, and the applied discount rate shifted from 9.5% to 11%.

This technical adjustment occurred because the new agreement eliminated the possibility of the fund receiving percentage-based rents tied to hospital revenues, locking income into a fixed model adjusted by the IPCA. Consequently, the property's explosive appreciation potential was traded for much greater contract security. Currently, the NSLU11 price on the secondary market trades around R$ 173.98, representing a steep discount to its book value per unit of R$ 253.21. This results in a P/BV ratio of 0.6871 (meaning investors buy the fund's assets at a discount, paying roughly R$ 68 for every R$ 100 of book value, as indicated by the 0.68 P/BV ratio in our previous analysis). This discount serves as an important margin of safety against the property's accounting write-down.

Is NSLU11 Worth It With the Current Selic Rate?

It depends on your investment horizon and liquidity needs, since the recurring dividend of R$ 1.72 per unit equates to an annualized yield of roughly 12% on the current price of R$ 173.98, falling below the 14.5% Selic rate. For investors seeking to maximize short-term returns and beat the benchmark interest rate today, NSLU11 is worth it only if they clearly understand the concentration risk. After all, traditional fixed-income instruments offer higher nominal yields with sovereign risk and daily liquidity.

However, the analysis changes when looking at the long term. NSLU11 offers a real rate of return (above inflation) backed by a 30-year contract with Rede D'Or, something extremely difficult to replicate in traditional fixed income without taking on reinvestment risk. While long-term government bonds suffer from mark-to-market volatility and shifting economic expectations, NSLU11 delivers a tax-free monthly cash flow indexed to the IPCA. Therefore, for investors focused on private retirement planning and decades of real income generation, the current price discount and contract predictability make the asset a highly robust defensive alternative, even in a high-rate environment.

What Are the Main Risks of the NSLU11 Real Estate Fund?

The fund's primary risk stems from its single-asset, single-tenant structure, concentrating 100% of its R$ 327 million net asset value in one property operated by a single tenant. If Rede D'Or faces severe financial distress, decides to discontinue operations at the Jabaquara unit, or if the building suffers major physical damage, the fund has no other assets to cushion the blow. The risk is binary: either the contract is fulfilled in full and unitholders receive their distributions, or operations halt and distributions drop to zero.

Another key point to watch is the inability to revise rent for the next nine years. The atypical lease signed in October 2025 prohibits any rent-revision actions through October 2034. This means that even if the Hospital Nossa Senhora de Lourdes becomes extremely profitable or if healthcare-specific inflation climbs well above the general IPCA, unitholders will not capture that real upside. Adjustments will remain strictly limited to accumulated IPCA variations. There is also the risk of discrepancies in withholding income tax (IRRF) deductions on extraordinary capital redemptions—an operational issue that recently sparked discussions within the investor community, since the 20% capital gains tax on redemptions depends on each unitholder's individual average acquisition cost, and administrator BTG Pactual does not automatically provide an individualized calculation ledger.

What Should Investors Monitor in NSLU11 Over Coming Months?

Investors should closely monitor the receipt of residual escrow deposit balances and the application of annual IPCA adjustments. The fund still holds roughly R$ 8.39 million in cash and R$ 2.44 million receivable in rents and pending judicial deposits. Collecting this R$ 2.4 million residual balance could trigger further one-off extraordinary distributions of up to R$ 1.85 per unit over coming quarters, acting as a bonus for unitholders holding the asset.

Additionally, the annual rent adjustment via the IPCA, traditionally occurring in April, should lift the fund's monthly real estate revenue toward an estimated R$ 2.54 million, consequently raising recurring distributions paid to unitholders. Our recommendation for NSLU11 remains HOLD. Investors who already own the asset should keep their units to enjoy predictable, inflation-indexed cash flows. For new entries, the investment requires understanding extreme concentration risks and accepting that the instrument functions as a long-duration private fixed-income security rather than a dynamic growth real estate fund.

Rico aos Poucos Verdict: HOLD

The payout of R$ 1.8055 per unit confirms that the fund is gently landing toward its recurring baseline of R$ 1.72 without operational turbulence. The book value discount (P/BV of 0.6871) offers an excellent margin of safety for those seeking IPCA-indexed income for decades, though concentration risk in a single hospital demands investor discipline.